These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 24006340

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumors.
    Barth RF, Yang W, Al-Madhoun AS, Johnsamuel J, Byun Y, Chandra S, Smith DR, Tjarks W, Eriksson S.
    Cancer Res; 2004 Sep 01; 64(17):6287-95. PubMed ID: 15342417
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Synthesis and biological evaluation of neutral and zwitterionic 3-carboranyl thymidine analogues for boron neutron capture therapy.
    Byun Y, Yan J, Al-Madhoun AS, Johnsamuel J, Yang W, Barth RF, Eriksson S, Tjarks W.
    J Med Chem; 2005 Feb 24; 48(4):1188-98. PubMed ID: 15715485
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synthesis of N3-substituted carboranyl thymidine bioconjugates and their evaluation as substrates of recombinant human thymidine kinase 1.
    Agarwal HK, McElroy CA, Sjuvarsson E, Eriksson S, Darby MV, Tjarks W.
    Eur J Med Chem; 2013 Feb 24; 60():456-68. PubMed ID: 23318906
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synthesis and biological evaluation of boronated nucleosides for boron neutron capture therapy (BNCT) of cancer.
    Tjarks W, Wang J, Chandra S, Ji W, Zhuo J, Lunato AJ, Boyer C, Li Q, Usova EV, Eriksson S, Morrison GH, Cosquer GY.
    Nucleosides Nucleotides Nucleic Acids; 2001 Feb 24; 20(4-7):695-8. PubMed ID: 11563094
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Synthesis, chemical and enzymatic hydrolysis, and aqueous solubility of amino acid ester prodrugs of 3-carboranyl thymidine analogs for boron neutron capture therapy of brain tumors.
    Hasabelnaby S, Goudah A, Agarwal HK, abd Alla MS, Tjarks W.
    Eur J Med Chem; 2012 Sep 24; 55():325-34. PubMed ID: 22889558
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nucleoside Scaffolds and Carborane Clusters for Boron Neutron Capture Therapy: Developments and Future Perspective.
    Khalil A, Adam MSS.
    Curr Med Chem; 2024 Sep 24; 31(35):5739-5754. PubMed ID: 37818562
    [Abstract] [Full Text] [Related]

  • 18. 3-Carboranyl thymidine analogues (3CTAs) and other boronated nucleosides for boron neutron capture therapy.
    Byun Y, Narayanasamy S, Johnsamuel J, Bandyopadhyaya AK, Tiwari R, Al-Madhoun AS, Barth RF, Eriksson S, Tjarks W.
    Anticancer Agents Med Chem; 2006 Mar 24; 6(2):127-44. PubMed ID: 16529536
    [Abstract] [Full Text] [Related]

  • 19. In vitro and in vivo evaluation of carboranyl uridines as boron delivery agents for neutron capture therapy.
    Liu L, Barth RF, Tjarks W, Soloway AH, Anisuzzaman AK.
    Anticancer Res; 1996 Mar 24; 16(1):113-20. PubMed ID: 8615595
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.